The Institute for Precision Medicine hosts a monthly lecture series to highlight advances in Precision Medicine research – not only at Pitt/UPMC but across the United States.
The second IPM lecture for the Fall 2021 semester will be given by Elaine Mardis, Ph.D., co-Executive Director of the Institute for Genomic Medicine at Nationwide Children’s Hospital at the Ohio State University.
Dr. Mardis has authored over 350 articles in prestigious peer-reviewed journals and has written book chapters for several medical textbooks. She serves as an associate editor for three peer-reviewed journals (Disease Models and Mechanisms, Molecular Cancer Research, and Annals of Oncology), is Editor-in-Chief of Molecular Case Studies and served as the President of the American Academy of Cancer Research (AACR) 2019-2020.
Dr. Mardis’s lecture will focus on the broad lessons from her work in pediatric cancer genomics and on new developments that will bring molecular characterization to the forefront of evidence-based diagnosis, prognosis, and treatment. She will discuss her group’s findings in high-grade CNS malignancies and comment on umbrella clinical trial designs that aid the translation of results to therapeutic modalities, focusing on the most prevalent drivers and pathways. Larger-scale testing is being funded by NCI, enabling broader application of these approaches to pediatric patients across the United States. These emerging studies parallel efforts around the world and portend a future where molecular profiling of pediatric cancers is standard of care.
Please mark your calendars for: October 13th at 4:00pm.
MEETING LINK: https://pitt.zoom.us/s/98013671834